AFATINIB (AFATINIB DIMALEATE) — all Canadian products
12 DINs
9 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is AFATINIB (AFATINIB DIMALEATE), with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02415666 | GIOTRIF | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Tablet | Oral | AFATINIB (AFATINIB DIMALEATE) 20 MG | Marketed | |
| 02415674 | GIOTRIF | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Tablet | Oral | AFATINIB (AFATINIB DIMALEATE) 30 MG | Marketed | |
| 02415682 | GIOTRIF | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Tablet | Oral | AFATINIB (AFATINIB DIMALEATE) 40 MG | Marketed | |
| 02517035 | MAR-AFATINIB | MARCAN PHARMACEUTICALS INC | Tablet | Oral | AFATINIB (AFATINIB DIMALEATE) 40 MG | Marketed | |
| 02517019 | MAR-AFATINIB | MARCAN PHARMACEUTICALS INC | Tablet | Oral | AFATINIB (AFATINIB DIMALEATE) 20 MG | Marketed | |
| 02517027 | MAR-AFATINIB | MARCAN PHARMACEUTICALS INC | Tablet | Oral | AFATINIB (AFATINIB DIMALEATE) 30 MG | Marketed | |
| 02512777 | SANDOZ AFATINIB | SANDOZ CANADA INCORPORATED | Tablet | Oral | AFATINIB (AFATINIB DIMALEATE) 20 MG | Marketed | |
| 02512785 | SANDOZ AFATINIB | SANDOZ CANADA INCORPORATED | Tablet | Oral | AFATINIB (AFATINIB DIMALEATE) 30 MG | Marketed | |
| 02512793 | SANDOZ AFATINIB | SANDOZ CANADA INCORPORATED | Tablet | Oral | AFATINIB (AFATINIB DIMALEATE) 40 MG | Marketed | |
| 02514591 | TEVA-AFATINIB | TEVA CANADA LIMITED | Tablet | Oral | AFATINIB (AFATINIB DIMALEATE) 20 MG | Cancelled Pre Market | |
| 02514605 | TEVA-AFATINIB | TEVA CANADA LIMITED | Tablet | Oral | AFATINIB (AFATINIB DIMALEATE) 30 MG | Cancelled Pre Market | |
| 02514613 | TEVA-AFATINIB | TEVA CANADA LIMITED | Tablet | Oral | AFATINIB (AFATINIB DIMALEATE) 40 MG | Cancelled Pre Market |
Browse other molecules: